ClinicalThought
View More
Axial manifestations are common in patients with PsA. How can we use the latest data on inhibition of IL-17A and IL-23 to better manage axial symptoms?
Hear expert insights on when to use interleukin inhibitors in the course of psoriatic arthritis.
Review key data on when to use interleukin inhibitors in the course of psoriatic arthritis.
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.